A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites
Autor: | Kana Fukui, Shoichiro Amari, Nobuyuki Yotani, Rika Kosaki, Kenichiro Hata, Motomichi Kosuga, Haruhiko Sago, Tetsuya Isayama, Yushi Ito |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | American Journal of Perinatology Reports, Vol 13, Iss 01, Pp e25-e28 (2023) |
Druh dokumentu: | article |
ISSN: | 2157-6998 2157-7005 |
DOI: | 10.1055/a-2028-7784 |
Popis: | We report a case of a patient with severe fetal hydrops and refractory ascites, diagnosed as mucopolysaccharidosis type VII (MPS VII) by whole-exome sequencing, and discharged at 5 months of age after long-term ventilatory management. A male neonate was born by emergency cesarean section due to fetal distress at 301/7 weeks' gestation. Physical examination and X-rays revealed pleural effusion, ascites, and generalized edema, indicating severe fetal hydrops. He underwent tracheal intubation because of respiratory distress that was attributed to massive ascites, pulmonary hypoplasia, and pulmonary hypertension. He received mechanical ventilation and inhaled nitric oxide therapy. Prednisone, octreotide, and a factor XIII preparation were used as the treatment for ascites, and the ascites gradually decreased. He was extubated within 2 months of age. At 4 months of age, the results of whole-exome sequencing of the cord blood showed a compound heterozygous mutation in the GUSB gene, the gene responsible for MPS VII. Enzyme replacement therapy was initiated, and the ascites was resolved. Careful systemic management, including lung-protective respiratory management and the early establishment of nutrition, is important for the long-term survival of infants with fetal hydrops, and early aggressive workup, including whole-genome sequencing for the cause, should be performed in the case of refractory ascites. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |